Downloads

Product information

Parsortix brochure – capture and harvest of circulating tumor cells

Publications

Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells
University Medical Centre Hamburg-Eppendorf (UKE) published by Clinical Chemistry, September 2016

A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells
University Medical Centre Hamburg-Eppendorf (UKE) published by International Journal of Cancer, January 2016

Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer
Cancer Research UK Manchester Institute and Christie NHS Foundation Trust, Manchester UK published by Royal Society of Chemistry Analyst publication, November 2015

Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System
Barts Cancer Institute, published by PLOS ONE on 23 September 2015

Posters

Antibody-free microfluidics-based circulating tumor cell enrichment by Parsortix and downstream molecular characterization by Quantigene branched DNA technology
MD Anderson as presented at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia, August 2016 (AACC 2016)

Surface marker independent enrichment of circulating or disseminated cancer cells from blood or lymph nodes using a micro-fluidic device
Fraunhofer ITEM as presented at the 24th Biennial Congress of the European Association for Cancer Research, July 2016 (EACR 2016)

A highly sensitive method for circulating tumour cell antigen quantification in liquid biopsy
ANGLE Research & Development Laboratory as presented at the 24th Biennial Congress of the European Association for Cancer Research, July 2016 (EACR 2016)

Combined circulating tumour cell (CTC) and circulating tumor DNA (ctDNA) analysis of blood from patients with pancreatic cancer 
Cancer Research UK Manchester Institute as presented at the American Association for Cancer Research Annual Meeting 2016, April 2016

The combination of Parsortix™ system and CellCelector™ micromanipulator enables the characterization of EpCAM negative circulating tumor cells in breast cancer
Heinrich-Heine University, Düsseldorf, Germany as presented at the 10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, March 2016

Detection and molecular characterization of EpCAM positive and EpCAM negative circulating tumour cells isolated from SCLC (small cell lung cancer) patients using an epitope independent platform
Cancer Research UK Manchester Institute, as presented at the 10th ISMRC International Symposium on Minimal Residual 

Integration of RNA and DNA blood borne cancer biomarkers
Cancer Research UK Manchester Institute, as presented at the 10th ISMRC International Symposium on Minimal Residual 

Circulating rare cells enable highly efficient cancer detection Medical University of Vienna, as presented at 18th ECCO – 40th ESMO European Cancer Congress September 2015

Intra-tumour heterogeneity in prostate cancer and the implication in CTC analysis
Barts Cancer Institute, as presented at a symposium hosted by the British Association for Cancer Research and Cancer Research UK on 11 June 2015

Circulating rare cells enable highly efficient cancer detection
Medical University of Vienna, as presented at the AACR conference April 2015

Enrichment and isolation of uncontaminated breast cancer cells from human blood samples
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, as presented at the AACR conference April 2015

Evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumor cells
SCRUK – Manchester, as presented at NCRI conference November 2014

Technical validation of a novel label-independent device to capture CTCs
The University Medical Center Hamburg-Eppendorf (UKE), as presented at ACTC Conference, October 2014